For the quarter ending 2025-11-30, CYDY has $8,935K in assets. $128,683K in debts. $4,982K in cash and cash equivalents.
| Balance Sheets | 2025-11-30 | 2025-08-31 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 4,982 | 9,332 | ||
| Prepaid expenses | 560 | 560 | ||
| Prepaid service fees | 3,297 | 3,458 | ||
| Total current assets | 8,839 | 13,350 | ||
| Other non-current assets | 96 | 133 | ||
| Total assets | 8,935 | 13,483 | ||
| Accounts payable | 14,245 | 14,175 | ||
| Accrued interest on convertible notes | 14,971 | 16,577 | ||
| Convertible notes payable, net | 27,200 | 27,200 | ||
| Accrued liabilities and compensation | 19,685 | 2,823 | ||
| Accrued dividends on convertible preferred stock-Series CPreferred Stock | 4,087 | 3,929 | ||
| Accrued dividends on convertible preferred stock-Series DPreferred Stock | 4,924 | 4,713 | ||
| Total current liabilities | 85,112 | 69,417 | ||
| Other liabilities (note 10) | 43,571 | 43,571 | ||
| Total liabilities | 128,683 | 112,988 | ||
| Preferred stock-Series BPreferred Stock | 0 | 0 | ||
| Preferred stock-Series CPreferred Stock | 0 | 0 | ||
| Preferred stock-Series DPreferred Stock | 0 | 0 | ||
| Common stock, 0.001 par value 2,250,000 shares authorized 1,266,139 and 1,249,460 issued, and 1,265,853 and 1,249,174 outstanding at november 30, 2025 and may 31, 2025, respectively | 1,266 | 1,257 | ||
| Additional paid-in capital | 794,919 | 792,564 | ||
| Accumulated deficit | -915,933 | -893,326 | ||
| Total stockholders' deficit | -119,748 | -99,505 | ||
| Total liabilities and stockholders' deficit | 8,935 | 13,483 | ||
CytoDyn Inc. (CYDY)
CytoDyn Inc. (CYDY)